David Streem, MD, Staff Psychiatrist, Department of Psychiatry and Psychology, Cleveland Clinic, discusses prescription medication and the responsibility of health professionals to patients and family alike to encourage…
Jonathan Sears, MD, Associate Professor of Ophthalmology, Cole Eye Institute, Cleveland Clinic, discusses reversing phase 1 and 2 of ROP by turning down oxygen levels to encourage retinal…
NEW YORK (Reuters Health) – Elevated triglyceride levels are an independent predictor of myelinated fiber density (MFD) loss in patients with mild to moderate diabetic neuropathy, according to…
NEW YORK (Reuters Health) – Subthalamic nucleus stimulation (STN) is more effective in relieving t motor symptoms of Parkinson’s disease than unilateral pallidotomy during long-term follow-up, physicians in…
NEW YORK (Reuters Health) – Although the rate of hysterectomy after cesarean delivery has declined over the past decade, the procedure remains an “uncommon, but not rare” complication…
NEW YORK (Reuters Health) – Pitavastatin is equivalent to atorvastatin in its ability to reduce coronary plaque volume in patients with acute coronary syndrome (ACS), Japanese researchers have…
Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses metastatic eye cancer that can be caused by any cancer, but most commonly carcinomas. Summary: Breast…
Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses retinoblastoma and treatment options, which include enucleation and radiation, chemotherapy, cryotherapy and TTT (transpulillary thermotherapy protocol).…
Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses chromosomal analysis within a tumor, the most important guide to clinical survival. Summary: Chromosal analysis of…
Jimmy K. Lee, MD, Director of Cornea and Refractive Surgery Sections, Yale Eye Center, discusses lasik or laser vision correction, which is a great option for those who…
